DBV Technologies SA (DBVT)

0.691 +0.01 (+1.62%) USD  |  NASDAQ  |  Apr 24, 16:00
More

DBV Technologies Total Assets (Quarterly): 182.99M for Dec. 31, 2023

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2011. Upgrade now.
Date Value
December 31, 2023 182.99M
September 30, 2023 189.78M
June 30, 2023 217.52M
March 31, 2023 232.93M
December 31, 2022 246.52M
September 30, 2022 248.12M
June 30, 2022 284.98M
March 31, 2022 117.58M
December 31, 2021 146.72M
September 30, 2021 170.92M
June 30, 2021 200.58M
March 31, 2021 221.40M
December 31, 2020 272.25M
June 30, 2020 337.01M
December 31, 2019 271.72M
September 30, 2019 168.81M
June 30, 2019 212.23M
June 30, 2019 212.23M
December 31, 2018 196.46M
June 30, 2018 289.36M
Date Value
June 30, 2018 289.36M
December 31, 2017 213.32M
June 30, 2017 272.16M
June 30, 2017 272.16M
December 31, 2016 302.36M
June 30, 2016 364.91M
June 30, 2016 364.91M
December 31, 2015 375.31M
June 30, 2015 133.48M
June 30, 2015 133.48M
December 31, 2014 152.51M
June 30, 2014 52.94M
June 30, 2014 52.94M
December 31, 2013 63.85M
June 30, 2013 50.45M
June 30, 2013 50.45M
December 31, 2012 56.83M
June 30, 2012 60.04M
December 31, 2011 20.38M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

117.58M
Minimum
Mar 2022
337.01M
Maximum
Jun 2020
218.57M
Average
214.88M
Median

Total Assets (Quarterly) Benchmarks

Edap TMS SA 101.20M
Cellectis SA 209.70M
Biophytis SA 13.22M
Genfit SA 192.20M
Adaptimmune Therapeutics PLC 282.62M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly) 42.80M
Shareholders Equity (Quarterly) 140.19M